Little Green Pharma Ltd. (AU:LGP) has released an update.
Little Green Pharma Ltd. has reported a 29% increase in revenue from ordinary activities, rising to $25,631,830 for the financial year ending 31 March 2024, compared to the previous year. Despite the revenue growth, the company experienced a 5% reduction in loss after tax, down to $(8,152,558). The firm did not propose or pay any dividends in this period and highlighted a slight decrease in net tangible assets per ordinary security.
For further insights into AU:LGP stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
